Similar articles

• [Oxidative stress and endothelial dysfunction in heart failure].

  Devaux C, Varin R, Mulder P, Richard V, Thuillez C. Devaux C, et al. Therapie. 2001 Sep-Oct;56(5):575-81. Therapie. 2001. PMID: 11806296 Review. French.
• Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.

  Tousoulis D, Charakida M, Stefanadis C. Tousoulis D, et al. Int J Cardiol. 2005 Apr 28;100(3):347-53. doi: 10.1016/j.ijcard.2004.05.030. Int J Cardiol. 2005. PMID: 15837076 Review.
• [Glucocorticoid-induced reduction in NO bioavailability and vascular endothelial dysfunction].

  Akaike M, Matsumoto T. Akaike M, et al. Clin Calcium. 2007 Jun;17(6):864-70. Clin Calcium. 2007. PMID: 17548925 Review. Japanese.
• Endothelial dysfunction in chronic heart failure: some new basic mechanisms.

  Bachetti T. Bachetti T. Ital Heart J. 2000 Oct;1(10):656-61. Ital Heart J. 2000. PMID: 11061361 Review.
• Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.

  Linz W, Itter G, Dobrucki LW, Malinski T, Wiemer G. Linz W, et al. J Renin Angiotensin Aldosterone Syst. 2003 Sep;4(3):180-5. doi: 10.3317/jraas.2003.029. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 14608524